David Giljohann

Close

David Giljohann

Chief Executive Officer, AuraSense Therapeutics LLC, Skokie, IL, USA.

Emphasis: We are developing biofunctionalized nanoparticles for gene regulation and detection.  Our “Smart-Flares” are now being sold commercially by Merck-Millipore.”

Advice: “Commercializing technology is a rush. There is tremendous feeling of accomplishment to see a project turn into a product you can buy.”